M. Dara (Copenhagen, Denmark), E. Huitric (Stockholm, Sweden)
Poor treatment outcomes of XDR-TB patients in resource-limited settings
G. Sotgiu, E. Pietersen, R. Centis, M. Davids, A. Piana, D. Vaghela, K. Kliiman, L. D‘Ambrosio, G. Theron, G.B. Migliori, K. Dheda (Sassari, Tradate, Italy; Cape Town, South Africa; Tartu, Estonia)
|  |
The incidence of multi drug resistant tuberculosis among patients receiving standardized treatment regimen for suspected MDR-TB
S. Augusto Jr., J. Gonong, L. Raymond, V. Lofranco, V. Balanag (Quezon City, Philippines)
| |
Non-pharmacological factors for the emergence of drug resistance in patients of pulmonary tuberculosis: An Indian overview
J. K. Samaria, S. Chaubey (Varanasi, Sawangi-Wardha, India)
| |
The efficacy of a rifabutin-containing regimen for rifabutin-susceptible multidrug-resistant tuberculosis
K.W. Jo, W. Ji, J. Lyu, Y.J. Jung, S.D. Lee, W.S. Kim, D.S. Kim, T.S. Shim (Seoul, Republic Of Korea)
|  |
Treatment outcomes of MDR-TB cases registered in Bucharest sector 4 during 2004-2008
M. Tigau, I. Dediu, E. Ibraim (Bucharest, Romania)
| |
Treatment outcome of multi drug resistant tuberculosis patients in modified DOTS-PLUS: A new strategy
R. Prasad, A. Singh, R. Srivastava, R.S. Kushwaha, R. Garg, S.K. Verma, G. Belur Hosmane, A. Jain, T.G. Ranganath (Etawah, Lucknow, India)
| |
Failures in treatment of patients according DOTS-PLUS program: Medico-social predictors
I. Felker (Tomsk, Russian Federation)
| |
Success of the patient-oriented approach to MDR-TB treatment in Tomsk Oblast, Russia, 2000-2009
S. Mishustin, P. Golubchikov, A. Barnashov, V. Bayerlen, A. Golubkov, D. Taran, N. Zemlyanaya, O. Ponomarenko, O. Sirotkina, V. Golubchikova, E. Anisimov (Tomsk, Russian Federation; Boston, United States Of America)
| |
Long term treatment outcome in multi drug resistant tuberculosis
R. Prasad, A. Singh, S. Verma, R.S. Kushwaha, R. Garg, S.K. Verma, R. Srivastava, A. Jain (Etawah, Lucknow, Kanpur, India)
| |
Peculiarities and results of treatment in XDR pulmonary tuberculosis (PTB)
S. Skornyakov, I. Motus, E. Kildyusheva (Ekaterinburg, Russian Federation)
| |
Evaluation of characteristics and treatment results of patients treated as multidrug resistant tuberculosis
M. Yalçinsoy, H. Arpag, T. Kuyucu, A. Baran, M. Partal, O.K. Köksalan, E. Akkaya (Istanbul, Turkey)
| |
Use of linezolid in complex MDR-TB cases
Y.W. Huang, H.C. Tsai, C.N. Chang, W.T. Yang (Puxin Town, Taichung, Taiwan)
| |
Treatment outcome and factors associated with unfavourable treatment results in cases with multidrug-resistant tuberculosis in Bulgaria for the period 2009-2010
V. Milanov, M. Zamfirova, T. Varleva, E. Bachiyska, A. Koleva (Sofia, Gabrovo, Bulgaria)
| |
The individual-tailored treatment regimens for multidrug-resistant tuberculosis
T. Ivanushkina, S. Borisov, N. Litvinova, Y. Garmash (Moscow, Russian Federation)
| |
Study of isoniazid-resistant tuberculosis including outcomes in a high prevalence area in London
G. Bhat, G. Packe (London, United Kingdom)
| |
Drug resistance trends and patterns of mycobacterium tuberculosis isolates from pulmonary tuberculosis patients at a tertiary care hospital in Turkey
E. Ertan Yazar, B.P. Yildiz, G. Günlüoglu, S. Altin, V. Yilmaz, D. Hirçin Cenger (Istanbul, Turkey)
| |
How big is the problem with MDR-TB cases in Macedonia?
B. Ilievska Poposka, M. Zakoska, C. Vragoterova, S. Talevski (Skopje, Fyrom)
| |
Comparison of moxifloxacin and ofloxacin in treatment of multidrug resistant pulmonary tuberculosis
H. Arpag, M. Yalçinsoy, E.N. Ordu, T. Kuyucu, S. Bilgin, E. Akkaya, M. Partal, O.K. Köksalan (Istanbul, Turkey)
| |